利多卡因耳后注射治疗突发性聋伴2型糖尿病的效果(1)
[摘要]目的 探讨利多卡因耳后注射治疗突发性聋伴2型糖尿病(T2MD)的效果。方法 选取2017年12月~2018年12月我院收治的60例突发性聋伴T2MD患者,按照随机数字表法分为对照组(30例)和研究组(30例)。对照组采用常规血液流变学治疗,研究组在对照组的基础上采用耳后注射利多卡因治疗。比较两组的效果及在治疗前、后行纯音听阈测定结果,各下降频率听力提高的绝对值。结果 研究组和对照组的治疗总有效率分别为83.33%和70.00%,差异无统计学意义(P>0.05);研究组治疗后纯音听阈测定结果低于对照组(P<0.05),在250~500 Hz和 >4000~8000 Hz区间的下降频率听力提高的绝对值高于对照组,差异有统计学意义(P<0.01)。结论 利多卡因耳后注射治疗突发性聋伴T2MD患者,效果显著,有助于患者的听力恢复。[关键词]突发性聋;2型糖尿病;利多卡因;耳后注射
[中图分类号] R764.437 [文献标识码] A [文章编号] 1674-4721(2019)10(b)-0148-03
[Abstract] Objective To explore the effect of retroauricular injection of Lidocaine in the treatment of sudden deafness with type 2 diabetes mellitus (T2MD). Methods A total of 60 patients with sudden deafness complicated with T2MD admitted to our hospital from December 2017 to December 2018 were selected and divided into control group (30 cases) and study group (30 cases) according to the random number table method. The control group was given routine hemorheology therapy ......
您现在查看是摘要页,全文长 4011 字符。